These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
539 related items for PubMed ID: 27470555
1. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis. Eissa S, Matboli M, Bekhet MM. Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555 [Abstract] [Full Text] [Related]
2. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R. PLoS One; 2016 Oct; 11(3):e0150154. PubMed ID: 26930277 [Abstract] [Full Text] [Related]
3. Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease. Eissa S, Matboli M, Aboushahba R, Bekhet MM, Soliman Y. J Diabetes Complications; 2016 Oct; 30(8):1585-1592. PubMed ID: 27475263 [Abstract] [Full Text] [Related]
4. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy. Li W, Yang S, Qiao R, Zhang J. Clin Lab; 2018 May 01; 64(5):709-718. PubMed ID: 29739042 [Abstract] [Full Text] [Related]
5. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy. Jia Y, Guan M, Zheng Z, Zhang Q, Tang C, Xu W, Xiao Z, Wang L, Xue Y. J Diabetes Res; 2016 May 01; 2016():7932765. PubMed ID: 26942205 [Abstract] [Full Text] [Related]
6. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis. Regmi A, Liu G, Zhong X, Hu S, Ma R, Gou L, Zafar MI, Chen L. Med Sci Monit; 2019 Mar 05; 25():1699-1708. PubMed ID: 30835718 [Abstract] [Full Text] [Related]
7. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'. Prabu P, Rome S, Sathishkumar C, Gastebois C, Meugnier E, Mohan V, Balasubramanyam M. Diabetes Metab; 2019 Jun 05; 45(3):276-285. PubMed ID: 30165157 [Abstract] [Full Text] [Related]
8. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan. Chien HY, Chen CY, Chiu YH, Lin YC, Li WC. Int J Med Sci; 2016 Jun 05; 13(6):457-65. PubMed ID: 27279796 [Abstract] [Full Text] [Related]
9. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Shoukry A, Bdeer Sel-A, El-Sokkary RH. Mol Cell Biochem; 2015 Oct 05; 408(1-2):25-35. PubMed ID: 26104579 [Abstract] [Full Text] [Related]
10. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study. Bessa SS, Hussein TA, Morad MA, Amer AM. Ren Fail; 2012 Oct 05; 34(6):670-5. PubMed ID: 22486214 [Abstract] [Full Text] [Related]
11. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy. Li Z, Xu Y, Liu X, Nie Y, Zhao Z. Nephrology (Carlton); 2017 Jan 05; 22(1):58-64. PubMed ID: 26733347 [Abstract] [Full Text] [Related]
12. Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease. Xie Y, Jia Y, Cuihua X, Hu F, Xue M, Xue Y. J Diabetes Res; 2017 Jan 05; 2017():6978984. PubMed ID: 29038788 [Abstract] [Full Text] [Related]
13. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1. Meng L, Li G, Liu X, Jiang J, Zhu M, Sun Y. Clin Lab; 2018 Jul 01; 64(7):1177-1182. PubMed ID: 30146830 [Abstract] [Full Text] [Related]
14. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy. Wang J, Wang G, Liang Y, Zhou X. J Diabetes Res; 2019 Jul 01; 2019():5204394. PubMed ID: 31218232 [Abstract] [Full Text] [Related]
15. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy. Han Q, Zhang Y, Jiao T, Li Q, Ding X, Zhang D, Cai G, Zhu H. Nutr Diabetes; 2021 Jun 30; 11(1):24. PubMed ID: 34193814 [Abstract] [Full Text] [Related]
16. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy. Abdel Ghafar MT, Shalaby KH, Okda HI, Abo El Gheit RE, Soliman NA, Keshk WA. J Investig Med; 2020 Mar 30; 68(3):748-755. PubMed ID: 31722957 [Abstract] [Full Text] [Related]
17. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis. Park S, Moon S, Lee K, Park IB, Lee DH, Nam S. Cell Physiol Biochem; 2018 Mar 30; 46(4):1331-1340. PubMed ID: 29689545 [Abstract] [Full Text] [Related]
18. Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles. Nossier AI, Shehata NI, Morsy SM, Saeed DF, Elsayed NM, Ismail MF, Eissa S. Anal Biochem; 2020 Nov 15; 609():113967. PubMed ID: 32950495 [Abstract] [Full Text] [Related]
19. Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease. Zang J, Maxwell AP, Simpson DA, McKay GJ. Sci Rep; 2019 Jul 29; 9(1):10900. PubMed ID: 31358876 [Abstract] [Full Text] [Related]
20. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients. El-Horany HE, Abd-Ellatif RN, Watany M, Hafez YM, Okda HI. IUBMB Life; 2017 Aug 29; 69(8):623-630. PubMed ID: 28631886 [Abstract] [Full Text] [Related] Page: [Next] [New Search]